New York, NY -- (SBWIRE) -- 03/25/2013 -- Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) traded in the range of $7.76 and $8.55 during its latest trading session. The stock had opened at $7.90 and is currently at $8.30, up 9.58 percent from its previous close of $7.57. Acadia Pharmaceuticals recorded the volume of 4.772 million shares, significantly higher than its average daily trading volume of 2.111 million shares, thus showing bullish trend. The stock is likely to maintain the streak and it may touch $8.70 in the coming trading sessions. Upon breaching this level, its second resistance level is at $8.88.
Acadia Pharmaceuticals develops small molecule drugs for treating central nervous system disorders.
Find out more on ACAD here:
ON Semiconductor Corp. (NASDAQ: ONNN) opened at $8.30 and oscillated in the range of $8.11 and $8.35 in the latest trading session. It is currently at $8.12, up 0.50 percent from its previous close of $8.08. ON Semiconductor shows bullish trend and the stock’s first resistance level is at $8.25. Upon breaching this level, the stock may touch $8.55. On the downside, it may slip to $7.98. ON Semiconductor has traded 5.373 million shares so far.
The company develops and markets semiconductor components. It is based out of Arizona and it was established in 1999.
Find out more on ONNN here:
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetreport.net/disclaimer-2/
WALL STREET REPORT
For more information on this press release visit: http://www.sbwire.com/press-releases/acadia-pharmaceuticalson-semiconductor-trend-analysis-reports-nasdaq-acad-nasdaq-onnn-228396.htm